<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: neurodegenerative conditions</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Scientists identify molecular trigger for Alzheimer's disease</title>
   	 <description>Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons in the brain.</description>
     <link>http://medicalxpress.com/news/2013-05-scientists-molecular-trigger-alzheimer-disease.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 20 May 2013 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news288269429</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/moleculartri.jpg" width="90" height="90" />
</item>
<item>
     <title>Normal prion protein regulates iron metabolism</title>
   	 <description>An iron imbalance caused by prion proteins collecting in the brain is a likely cause of cell death in Creutzfeldt-Jakob disease (CJD), researchers at Case Western Reserve University School of Medicine have found.</description>
     <link>http://medicalxpress.com/news/2013-03-prion-protein-iron-metabolism.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Wed, 13 Mar 2013 12:46:49 EST</pubDate>
	 <guid isPermaLink="false">news282397602</guid>
	 
</item>
<item>
     <title>Green tea extract interferes with the formation of amyloid plaques in Alzheimer's disease</title>
   	 <description>(Medical Xpress)—Researchers at the University of Michigan have found a new potential benefit of a molecule in green tea: preventing the misfolding of specific proteins in the brain.</description>
     <link>http://medicalxpress.com/news/2013-03-green-tea-formation-amyloid-plaques.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Tue, 05 Mar 2013 13:29:57 EST</pubDate>
	 <guid isPermaLink="false">news281712578</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/greenteaextr.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists identify molecular system that could help develop potential treatments for neurodegenerative diseases</title>
   	 <description>Scientists from the University of Southampton have identified the molecular system that contributes to the harmful inflammatory reaction in the brain during neurodegenerative diseases.</description>
     <link>http://medicalxpress.com/news/2013-02-scientists-molecular-potential-treatments-neurodegenerative.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 21 Feb 2013 08:42:01 EST</pubDate>
	 <guid isPermaLink="false">news280658504</guid>
	 
</item>
<item>
     <title>New understanding can lead to srategies for dealing with neurodegenerative diseases</title>
   	 <description>A new understanding of what takes place on the cellular level during the development of neurodegenerative diseases, such as Parkinson's, Alzheimer's, ALS and Huntington's diseases, offers promise towards possible new strategies for combating such diseases, say Hebrew University of Jerusalem researchers.</description>
     <link>http://medicalxpress.com/news/2012-12-srategies-neurodegenerative-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 06 Dec 2012 10:44:36 EST</pubDate>
	 <guid isPermaLink="false">news274013065</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/2-newunderstan.jpg" width="90" height="84" />
</item>
<item>
     <title>Neurons made from stem cells drive brain activity after transplantation in laboratory model</title>
   	 <description>(Medical Xpress)—Researchers and patients look forward to the day when stem cells might be used to replace dying brain cells in Alzheimer's disease and other neurodegenerative conditions. Scientists are currently able to make neurons and other brain cells from stem cells, but getting these neurons to properly function when transplanted to the host has proven to be more difficult. Now, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have found a way to stimulate stem cell-derived neurons to direct cognitive function after transplantation to an existing neural network. The study was published November 7 in the Journal of Neuroscience.</description>
     <link>http://medicalxpress.com/news/2012-11-neurons-stem-cells-brain-transplantation.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 15 Nov 2012 15:14:18 EST</pubDate>
	 <guid isPermaLink="false">news272214851</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/neuronsmadef.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists block toxic protein that plays key role in Lou Gehrig's disease</title>
   	 <description>October 28, 2012— Scientists at the Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein found in nerve cells. These findings point to a potential new tactic for treating a variety of neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease)—a fatal disease for which there is no cure.</description>
     <link>http://medicalxpress.com/news/2012-10-scientists-block-toxic-protein-key.html</link>
	 <category>Medical research</category>
	 <pubDate>Sun, 28 Oct 2012 13:00:01 EST</pubDate>
	 <guid isPermaLink="false">news270630020</guid>
	 
</item>
<item>
     <title>Drug shows promise in animal model of Alzheimer's and Parkinson's with dementia</title>
   	 <description>New research presented in October at the 6th Neurodegenerative Conditions Research and Development Conference in San Francisco demonstrates the role of the investigational compound IRX4204 in alleviating cognitive decline in animal models of Alzheimer's disease (AD). The presentation entitled &quot;Investigation of the RXR-specific agonist IRX4204 as a Disease Modifying Agent of Alzheimer's Disease Neuropathology and Cognitive Impairment&quot; was made by lead researcher Giulio Maria Pasinetti, MD, PhD, of the Mount Sinai School of Medicine in New York City.</description>
     <link>http://medicalxpress.com/news/2012-10-drug-animal-alzheimer-parkinson-dementia.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Fri, 26 Oct 2012 14:10:01 EST</pubDate>
	 <guid isPermaLink="false">news270475571</guid>
	 
</item>
<item>
     <title>Study examines delayed, misdiagnosis of sporadic Jakob-Creutzfeldt disease</title>
   	 <description>A medical record review study of 97 patients with the fatal, degenerative brain disorder sporadic Jakob-Creutzfeldt disease (sCJD) suggests that a correct diagnosis of the disease was often delayed by a variety of misdiagnoses, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-09-misdiagnosis-sporadic-jakob-creutzfeldt-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 24 Sep 2012 16:00:07 EST</pubDate>
	 <guid isPermaLink="false">news267704801</guid>
	 
</item>
<item>
     <title>Study reveal brain cells' weakest links</title>
   	 <description>(Medical Xpress)—People with degenerative neurological conditions could benefit from research that shows why their brain cells stop communicating properly.</description>
     <link>http://medicalxpress.com/news/2012-09-reveal-brain-cells-weakest-links.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Fri, 21 Sep 2012 09:13:41 EST</pubDate>
	 <guid isPermaLink="false">news267437610</guid>
	 
</item>
<item>
     <title>Rejected drug may protect against toxic substance common to Alzheimer's and Parkinson's diseases</title>
   	 <description>The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.</description>
     <link>http://medicalxpress.com/news/2012-08-drug-toxic-substance-common-alzheimer.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 13 Aug 2012 11:31:28 EST</pubDate>
	 <guid isPermaLink="false">news264076253</guid>
	 
</item>
<item>
     <title>Two proteins offer a 'clearer' way to treat Huntington's disease</title>
   	 <description>In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington's disease (HD).</description>
     <link>http://medicalxpress.com/news/2012-07-proteins-clearer-huntington-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 11 Jul 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news261230666</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/twoproteinso.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers design new substances that might help fight Alzheimer's and Parkinson's disease</title>
   	 <description>University of Granada researchers have tested melatonin analogues in rats that inhibit the enzyme nitric oxide synthase, which is involved in the development of the diseases referred above.</description>
     <link>http://medicalxpress.com/news/2012-06-substances-alzheimer-parkinson-disease.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 13 Jun 2012 10:33:16 EST</pubDate>
	 <guid isPermaLink="false">news258802352</guid>
	 
</item>
<item>
     <title>Scientists discover gene which causes rare disease in babies</title>
   	 <description>A rare disease which often first presents in newborn babies has been traced to a novel genetic defect, scientists at Queen Mary, University of London have found.</description>
     <link>http://medicalxpress.com/news/2012-05-scientists-gene-rare-disease-babies.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 29 May 2012 12:34:22 EST</pubDate>
	 <guid isPermaLink="false">news257513647</guid>
	 
</item>
<item>
     <title>Patients to benefit from better advice on pain control</title>
   	 <description>New UK guidance for doctors and other prescribers on the use of strong painkillers for patients with chronic or incurable disease has been welcomed by researchers at the University of Leeds.</description>
     <link>http://medicalxpress.com/news/2012-05-patients-benefit-advice-pain.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 23 May 2012 10:37:42 EST</pubDate>
	 <guid isPermaLink="false">news256988249</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/patientstobe.jpg" width="90" height="90" />
</item>
<item>
     <title>Observations refute widely held view on causal mechanism in amyotrophic lateral sclerosis</title>
   	 <description>In science, refuting a hypothesis can be as significant as proving one, all the more so in research aimed at elucidating how diseases proceed with a view toward preventing, treating, or curing them. Such a discovery can save scientists from spending precious years of effort exploring a dead end. In a study published in the Proceedings of the National Academy of Sciences, Munich-based researchers refute a widely accepted hypothesis about a causative step in neurodegenerative conditions. These results deal specifically with animal models of human amyotrophic lateral sclerosis (ALS, aka Lou Gehrig's disease) but also raise questions for research on other neurodegenerative diseases, such as Alzheimer's or Huntington's disease.</description>
     <link>http://medicalxpress.com/news/2012-02-refute-widely-held-view-causal.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 29 Feb 2012 17:40:42 EST</pubDate>
	 <guid isPermaLink="false">news249759567</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/observations.jpg" width="90" height="90" />
</item>
<item>
     <title>Lithium profoundly prevents brain damage associated with Parkinson's disease</title>
   	 <description>Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.</description>
     <link>http://medicalxpress.com/news/2011-06-lithium-profoundly-brain-parkinson-disease.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Fri, 24 Jun 2011 04:14:26 EST</pubDate>
	 <guid isPermaLink="false">news228107624</guid>
	 
</item>


</channel>
</rss>
